Release 5 Preview #3

This page is part of the FHIR Specification (v4.5.0: R5 Preview #3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3

Medicationadministration0310

Pharmacy Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: Device, Encounter, Patient, Practitioner, RelatedPerson

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile MedicationAdministration.

Generated Narrative

id: medadmin0310

status: completed

medication:

subject: Donald Duck. Generated Summary: id: pat1; Medical record number: 654321 (USUAL); active; Duck Donald (OFFICIAL); gender: male;

occurence: 16/01/2015 8:03:00 AM --> 16/01/2015 12:03:00 PM

Performers

-Actor
*Patrick Pump. Generated Summary: id: f007; id: 874635264 (OFFICIAL), id: 567IUI51C154 (USUAL); Simone Heps (OFFICIAL); ph: 020556936(WORK), S.M.Heps@bmc.nl(WORK), fax: 0205669283(WORK); gender: female; birthDate: 1971-11-07

request: Generated Summary: id: medrx0306; id: 12345689 (OFFICIAL); status: active; intent: order; Myleran 2mg tablet; authoredOn: 2015-01-15; Chronic myeloid Leukemia (disorder);

Dosages

-TextRouteDose
*6 mg PO daily for remission induction; adjust dosage to white blood cell (WBC) count. With hold treatment if WBC is less than 15,000/µL; resume when WBC is greater than 50,000/µLOral route (qualifier value)6 mg

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.